DK164202C - Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling - Google Patents

Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Info

Publication number
DK164202C
DK164202C DK058387A DK58387A DK164202C DK 164202 C DK164202 C DK 164202C DK 058387 A DK058387 A DK 058387A DK 58387 A DK58387 A DK 58387A DK 164202 C DK164202 C DK 164202C
Authority
DK
Denmark
Prior art keywords
alfa
procedures
preparation
pharmaceutical preparations
topical use
Prior art date
Application number
DK058387A
Other languages
Danish (da)
English (en)
Other versions
DK164202B (da
DK58387D0 (da
DK58387A (da
Inventor
Helmut Franz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK58387D0 publication Critical patent/DK58387D0/da
Publication of DK58387A publication Critical patent/DK58387A/da
Publication of DK164202B publication Critical patent/DK164202B/da
Application granted granted Critical
Publication of DK164202C publication Critical patent/DK164202C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK058387A 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling DK164202C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863603444 DE3603444A1 (de) 1986-02-05 1986-02-05 Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3603444 1986-02-05

Publications (4)

Publication Number Publication Date
DK58387D0 DK58387D0 (da) 1987-02-04
DK58387A DK58387A (da) 1987-08-06
DK164202B DK164202B (da) 1992-05-25
DK164202C true DK164202C (da) 1992-10-19

Family

ID=6293372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK058387A DK164202C (da) 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Country Status (20)

Country Link
EP (1) EP0231816B1 (no)
JP (1) JPS62209024A (no)
KR (1) KR870007698A (no)
AT (1) ATE63823T1 (no)
AU (1) AU601712B2 (no)
CA (1) CA1295242C (no)
DD (1) DD284602A5 (no)
DE (2) DE3603444A1 (no)
DK (1) DK164202C (no)
ES (1) ES2028796T3 (no)
FI (1) FI86144C (no)
GR (1) GR3002270T3 (no)
HU (1) HU196560B (no)
IE (1) IE59697B1 (no)
IL (1) IL81472A0 (no)
NO (1) NO169638C (no)
NZ (1) NZ219169A (no)
PH (1) PH24377A (no)
PT (1) PT84243B (no)
ZA (1) ZA87793B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275804A (en) * 1986-02-25 1994-01-04 E. B. Michaels Research Associates, Inc. Process and composition for oral hygiene
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3803312A1 (de) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Verwendung eines interferonenthaltenden gels
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
ATE110571T1 (de) * 1988-05-06 1994-09-15 Toray Industries Stabile interferon-beta-zusammensetzung.
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
CA2120950A1 (en) * 1991-10-11 1993-04-15 Mark C. Gillies Treating ophthalmic fibrosis using interferon-alpha
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
JP4536194B2 (ja) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 安定な注射用製剤
CN100488517C (zh) * 2000-03-07 2009-05-20 拉什-长老会-圣路加医学中心 捕获和灭活病原性微生物和精子的组合物及其制药用途
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
CA2464889A1 (en) * 2001-11-02 2003-05-08 Sekisui Chemical Co., Ltd. Cytokine-inducing material and cytokine-inducing instrument
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
KR101673044B1 (ko) * 2009-05-29 2016-11-04 이노닉스 테크놀로지스, 인코포레이티드 인간 병원체의 전염을 감소시키는데 사용하기 위한 조성물
CA2866115C (en) 2012-03-01 2020-03-24 Firststring Research, Inc. Topical gels containing alpha connexin c-terminal (act) peptides
JP6081156B2 (ja) * 2012-11-15 2017-02-15 アルケア株式会社 ハイドロゲル
DE102012222365A1 (de) 2012-12-05 2014-06-05 Aesculap Ag Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
CA2913115A1 (en) * 2013-06-09 2014-12-18 Efranat Ltd. Compositions comprising gc-macrophage activating factor and uses thereof
WO2018143911A1 (en) 2017-01-31 2018-08-09 Kimberly-Clark Worldwide, Inc. Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
DE3484951D1 (de) * 1983-10-14 1991-09-26 Sumitomo Pharma Verlaengerte praeparate mit verzoegerter abgabe.
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60260523A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd インタ−フエロンの凍結乾燥医薬組成物

Also Published As

Publication number Publication date
DE3603444A1 (de) 1987-08-06
NO169638B (no) 1992-04-13
HU196560B (en) 1988-12-28
DE3770280D1 (de) 1991-07-04
DD284602A5 (de) 1990-11-21
FI870457A (fi) 1987-08-06
EP0231816A3 (en) 1987-09-23
FI870457A0 (fi) 1987-02-03
PT84243A (de) 1987-03-01
AU601712B2 (en) 1990-09-20
NO870441L (no) 1987-08-06
DK164202B (da) 1992-05-25
HUT43494A (en) 1987-11-30
FI86144C (fi) 1992-07-27
ES2028796T3 (es) 1992-07-16
IL81472A0 (en) 1987-09-16
EP0231816A2 (de) 1987-08-12
GR3002270T3 (en) 1992-12-30
EP0231816B1 (de) 1991-05-29
IE870295L (en) 1987-08-05
KR870007698A (ko) 1987-09-21
PT84243B (pt) 1989-09-14
ZA87793B (en) 1988-10-26
DK58387D0 (da) 1987-02-04
CA1295242C (en) 1992-02-04
IE59697B1 (en) 1994-03-23
JPS62209024A (ja) 1987-09-14
AU6829287A (en) 1987-08-06
DK58387A (da) 1987-08-06
PH24377A (en) 1990-06-13
ATE63823T1 (de) 1991-06-15
NO169638C (no) 1992-07-22
NO870441D0 (no) 1987-02-04
FI86144B (fi) 1992-04-15
NZ219169A (en) 1990-04-26

Similar Documents

Publication Publication Date Title
DK164202C (da) Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling
DK203787D0 (da) Praeparat til nasal administrering
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
DK409786A (da) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter
DK144885A (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
MY104088A (en) Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
EP0355899A3 (en) Nucleotide derivatives
DK454588D0 (da) Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
LV5757A4 (lv) Jauni ligstosas izdalisanas farmaceitiski preparati
DK454185A (da) Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner
ATE68975T1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins

Legal Events

Date Code Title Description
PBP Patent lapsed